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Scope: Early-life exposures are critical in fetal programming and may influence function and
health in later life. Adequate maternal folate consumption during pregnancy is essential for
healthy fetal development and long-term offspring health. The mechanisms underlying fetal
programming are poorly understood, but are likely to involve gene regulation. Epigeneticmarks,
including DNA methylation, regulate gene expression and are modifiable by folate supply. We
observed transcriptional changes in fetal liver in response to maternal folate depletion and
hypothesized that these changes are concomitant with altered gene promoter methylation.
Methods and results: Female C57BL/6Jmice were fed diets containing 2 or 0.4mg folic acid/kg
for 4wk before mating and throughout pregnancy. At 17.5-day gestation, genome-wide gene
expression and promoter methylation were measured by microarray analysis in male fetal
livers. While 989 genes were differentially expressed, 333 promoters had altered methylation
(247 hypermethylated, 86 hypomethylated) in response to maternal folate depletion. Only
16 genes had both expression and methylation changes. However, most methylation changes
occurred in genomic regions neighboring expression changes.
Conclusion: In response to maternal folate depletion, altered expression at the mRNA level
was not associated with altered promoter methylation of the same gene in fetal liver.
Keywords:
Development / DNA methylation / Folate / Gene expression / Programming
 Additional supporting information may be found in the online version of this article atthe publisher’s web-site
1. Introduction
The developmental origins of health and disease hypothesis
suggests that exposures during early life are critical in alter-
ing the programming of a developing fetus, and that adverse
Correspondence: Jill A. McKay
E-mail: jill.mckay@ncl.ac.uk
Abbreviations: NTD, neural tube defect; PGE, positional gene
enrichment; SAM, S-adenosyl-methionine
exposuresmay predispose to the development of noncommu-
nicable disease(s) in later life. Such adverse exposures include
under- and overnutrition during fetal and neonatal develop-
ment, which increase susceptibility to a wide range of adult
diseases [1]. Adequate maternal consumption of folate (one
of the group of B vitamins) during pregnancy is essential to
ensure healthy fetal development and, in particular, to protect
against the development of neural tube defects (NTDs) [2, 3].
Further epidemiological evidence suggests that folate sup-
plementation during pregnancy may also reduce the risk of
other congenital defects [4] and adverse pregnancy outcomes
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[5], as well enhancing neurodevelopment [6] and reducing
the risk of severe language delay [7], autism [8, 9], and some
cancers (leukemia [10–12], brain tumors [13, 14], and neu-
roblastoma [15]) [16] in children. Moreover, folate deficiency
during pregnancy in rodents can cause spontaneous abor-
tion, teratogenic effects in offspring, reduced litter numbers,
and altered body weight of offspring [17, 18], emphasizing
the essentiality of sufficient maternal folate intake for suc-
cessful pregnancy outcomes, normal fetal development, and
long-term offspring health.
The mechanisms underlying such fetal programming
events are poorly understood, but are likely to involve changes
in gene regulation. Given the critical importance of ensur-
ing that cells express the appropriate consortium of genes to
match their circumstances, it is not surprising that a wide
range of mechanisms are employed in the regulation of gene
expression, including mechanisms involved in transcription
of genomic sequences tomRNA. In addition to specificity fac-
tors, repressors, transcription factors, activators, enhancers,
and silencers, all of which influence gene transcription, epi-
genetic mechanisms provide a further-integrated machin-
ery for transcriptional control. Epigenetic marks, including
DNAmethylation and histonemodifications, are copied from
one cell generation to the next and these epigenetic marks
and noncoding microRNAs (miRNA) work together as the
“epigenome” to regulate gene expression [19, 20]. Impor-
tantly, multiple environmental factors alter epigenetic pat-
terns, and in particular DNA methylation, suggesting that
epigenetic processes are a mediating mechanism by which
environmental factors influence gene transcription [21] and
cell function. Folate is central to one-carbon metabolism and
to the formation of the universal methyl donor S-adenosyl-
methionine (SAM), which is critical for the methylation of
biological molecules including DNA, lipids, and proteins. In-
deed the influence of dietary folate intake on DNA methy-
lation patterns has been reported widely in human [22–26]
and animal studies [27–31], but few studies have examined
the effects of this methylation change on gene transcription.
To our knowledge, no study has investigated the impact of
dietary folate alone on both gene expression and methylation
at the genome-wide level.
We have observed widespread transcriptional changes
(555 upregulated and 434 downregulated genes) in the
fetal livers of male C57BL/6J offspring at 17.5-day gestation
whosemothers were fed diets containing 0.4mg folic acid/kg
for 4wk before mating and throughout pregnancy compared
with controls (i.e., mothers fed 2mg folic acid/kg; McKay
et al., “Organ-specific gene expression changes in the fetal
liver and placenta in response to maternal folate depletion,”
currently under review). Given its role in SAMproduction, we
hypothesized that these transcriptional changes in response
to folate intake may be due to altered epigenetic regulation
of gene expression, more specifically, by the modification of
DNAmethylation patterns. To test this hypothesis, we investi-
gated genome-wide promoter methylation status in the fetal
liver in response to maternal folate depletion. To facilitate
the integration of transcriptomic and epigenomic datasets,
methylation analysis was carried out in the same animals
in which genome-wide gene expression had been quantified
previously.
2. Materials and methods
2.1 Animal husbandry and experimental diets
All animal procedures were approved by the Newcastle Uni-
versity Ethics Review Committee and the UK Home Office
(project license number 60/3979) and have been described
previously [29]. Animals were housed in the Comparative Bi-
ology Centre, Newcastle University, at 20–22C and with 12-h
light and dark cycles. Fresh water was available ad libitum.
Female C57BL/6J mice were allocated at random to either
a low-folate (0.4 mg folic acid/kg diet) or normal-folate diet
(2 mg folic acid/kg diet; 6 g of allocated diet was offered to
each mouse per day), and maintained on this diet for 4 wk
prior to mating. Diet compositions were modified from AIN-
93G [32] and have been described previously [29]. Mice were
time mated, that is, a male was added to a cage containing
two females overnight and removed the following morning.
Pregnant females, identified by the presence of a vaginal plug,
were recaged and offered 10 g/day of allocated diet through-
out pregnancy. At 17.5-day gestation, dams were killed for
collection of blood and tissues.
2.2 Sample collection
Animals were anesthetized using gaseous isoflurane, and an-
imals killed by cervical dislocation. The uterus, containing all
fetuses and placentas, was removed and placed immediately
in ice-cold PBS. The liver of each fetuswas removed, weighed,
and snap frozen in liquid nitrogen and stored at –80C.
2.3 RNA extraction, gene expression arrays, and
validation using real-time PCR
RNA extraction protocols, array hybridization, and subse-
quent data analyses have been described and data presented
elsewhere (McKay et al., “Organ-specific gene expression
changes in the fetal liver and placenta in response to mater-
nal folate depletion,” currently under review). Briefly RNA
was extracted from fetal livers of males only using Tri-
reagent (Sigma-Aldrich) and following the manufacturer’s
instructions. Genome-wide transcript abundance was deter-
mined by ServiceXS (Plesmanlaan 1/D, 2333 BZ Leiden,
the Netherlands) on the Affymetrix GeneChip platform with
the NuGO mouse array (NuGO_Mm1a520177). This ar-
ray comprises over 24 000 probe sets, covering the major-
ity of established genes. All raw and processed microar-
ray data have been deposited in the ArrayExpress database
E-MTAB-3940.
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Figure 1. Schema depicting study design and sample selection for genome-wide analyses.
2.4 DNA extraction
DNA was extracted from male fetal livers using Tri-reagent
(Sigma-Aldrich) as per manufacturer’s instructions. Briefly,
50 mg tissue was homogenized in 500 L Tri-reagent on ice.
A further 500 L tri-reagent and 200 L chloroform were
added, the sample was mixed by inversion and incubated on
ice for 5 min. Samples were centrifuged at 13 500 rpm for
15 min at 4C. The upper aqueous phase was removed, and
300 L 100% ethanol added to the lower phases, mixed by in-
version, and incubated for 2 min at room temperature before
centrifugation at 2000 × g for 5 min at 40C. The supernatant
was removed, and the pellet was washed twice, incubating
at room temperature for 30 min in 1 mL of 0.1 M sodium
citrate in 10% ethanol with periodic mixing, followed by cen-
trifugation at 2000 × g for 5 min at 4C. The DNA pellet was
suspended in 1.5 mL 75 % ethanol for 20 min at room tem-
perature with periodic mixing, followed by centrifugation at
2000× g for 5min at 4C. Ethanol was removed and the pellet
allowed to air dry for 3–5min at room temperature. DNAwas
resuspended in 300 L 8 M NaOH and purity and concentra-
tion were determined using a Nanodrop Spectrophotometer
(ThermoScientific).
2.5 Methylated DNA immunoprecipitation and
methylation array hybridization
The methylated DNA immunoprecipitation (MeDIP) proto-
col has been described in detail elsewhere [33]. For six litters
in which transcriptomic analysis had been carried out (n = 3
per dietary group), DNA was pooled for three male fetuses
per litter (5 g/fetus) prior to preparation for MeDIP (see
Fig. 1 for overview of study design). Briefly, 10 g of DNA
was incubated at 37C for 30 min with 20 L A/T1 RNase
(Fermentas) in a 500 L volume. DNA was sonicated in cold
water for 2 min at 20% pulse and 5 V of power output with an
Ultrasonic Homogenizer 4710 Series (Cole-Parmer Instru-
ment). Extent of sonication was assessed by loading 15 L
sample on a 1% agarose gel with 0.4 g/mL of ethidium bro-
mide. Successfully fragmented DNA samples (200–1000 bp)
were concentrated with silica columns (Zymo Research) to
50 L in TE buffer. To assess the success of the immuno-
precipitation, genomic DNA was spiked with positive (i.e.,
methylated) and negative (i.e., unmethylated) control PCR
products derived from lambda phage DNA (described previ-
ously [33]). Reaction mixtures were prepared by adding 40 ng
of positive control and 40 ng negative control to 4.4 g of
sonicated DNA in a total volume of 495 L of TE buffer. After
10 min of denaturation at 95C, samples were cooled on ice
for 10min and one-tenth of the reaction volumewas stored as
input at 4C. Immunoprecipitation reactions were performed
as described previously [33]. PCR amplification of spiked pos-
itive and negative controls for bothMeDIP and input samples
was carried out to confirm methylated controls were present
in both MeDIP and input samples, and that unmethylated
amplicons were present only in input samples (see Lisanti
et al. [33] for details of PCR, data not shown). Whole-genome
amplification of MeDIP and input samples was carried out
using a WGA2 kit (Sigma) following the manufacturer’s in-
structions, with 20 ng of template DNA and omitting the frag-
mentation step. Products of theWGA reactions were purified
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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on silica columns (Qiagen) and elutions were performed with
50 L water. Prior to array hybridization, quantitative PCR
was carried out to confirm the enrichment ofmethylatedDNA
inMeDIP comparedwith corresponding input samples as de-
scribed previously [33] (data not shown). Five micrograms of
MeDIP and input DNA were sent to NimbleGen Roche for
hybridization to two-channelMM8_RefSeq_promotermethy-
lation arrays.
All samples passed the quality control analysis performed
in the arrayQualityMetrics package [34]. Next, the raw DNA
methylation data were normalized using T-quantile normal-
ization applied across samples and separately on the two
channels [35] (corresponding to the MeDIP (Cy5, 635nm)
and input DNA samples (Cy3, 532nm), respectively). Then,
for each diet, enrichment scores were calculated, defined
as the negative log10-transformed p-value obtained from a
Kolmogorov–Smirnov sliding window approach. This ap-
proach assesses whether the probe intensities (defined as the
log2-transformed ratio between the channels, i.e., the MeDIP
and input DNA intensities) observed in a genomic window
(for all samples together; n = 3) are significantly higher than
that expected from the complete intensity distribution of all
probes. The genomic window size was set at 750 bp and only
genomic windows with at least four probes were considered,
in accordance with the manufacturer’s guidelines. The aver-
age probe-spacing for the array is 100 bp, yielding on average
sevenmeasurements per genomic window. Next, for each an-
notated promoter and for each diet only the genomic window
with the highest enrichment score, in addition to the corre-
sponding genomic window for the other diet, was considered
for further analysis.
Finally, for each sample (n = 6) DNA methylation inten-
sity values were calculated based on the mean probe inten-
sity value in each considered genomic window. To assess
differences in methylation intensity between diets (n = 3
for each diet), a linear modeling approach implementing
heteroscedasticity-consistent standard errors [36] was applied
using the lmtest and sandwich packages in R. This yielded a
differential methylation p-value and a differential methyla-
tion fold change. Genes were considered to be significantly
differentially methylated in response to low maternal folate
intake if there was a significant (p < 0.05) fold change of at
least ±1.2 fold. All raw and processed microarray data have
been deposited in the ArrayExpress database E-MTAB-4013.
2.6 Gene ontology enrichment and pathway
analysis
DAVID [37] was used to carry out Gene Ontology enrich-
ment analysis and to investigate KEGG pathways affected by
maternal folate depletion through changes in gene expres-
sion and DNA methylation. The threshold for significance
for Gene Ontology enrichment analysis was set at p < 0.05
(corrected for multiple testing), and at p< 0.05 (uncorrected)
for KEGG pathway enrichment analysis. Additional pathway
analysis was carried out using PathVisio [38] 3.2.0 and the
curated pathway collection of WikiPathways [39] (download
date: 01-09-2015), applying a significant (p< 0.05) fold change
of at least±1.2 fold, imposing aZ-score of 1.9 for significance
to filter for probable changed pathways
2.7 Positional gene enrichment (PGE) analysis
PGE analysis was carried out using the web-based PGE tool
(http://homes.esat.kuleuven.be/bioiuser/pge/index.php)
[40] to locate overrepresented chromosomal regions for
significantly upregulated, downregulated, hypermethylated,
and hypomethyled genes in the fetal liver in response to low
maternal folate intake.
This tool applies an algorithm using the hypergeometric
distribution to test if a chromosomal region is enriched in a
given set of genes. A region is determined to be pertinent if
it contains at least two genes of interest, there is no smaller
region containing the same genes of interest, there is no
bigger region withmore genes of interest and the same genes
not of interest, there is no larger encompassing region with
a higher percentage of genes of interest, there is no smaller
encompassed region with a better p-value, and it does not
contain any region having less than expected genes of interest
[40]. Resultant data were mapped to chromosomal locations
using Ensembl (http://www.ensembl.org).
3 Results
3.1 Influence of maternal folate intake during
pregnancy on gene expression in the fetal liver
Changes in gene expression in fetal liver in response tomater-
nal folate depletion have been described in detail elsewhere
(McKay et al., “Organ-specific gene expression changes in
the fetal liver and placenta in response to maternal folate
depletion,” currently under review). In summary, 989 genes
were differentially expressed, of which 555 were upregulated
and 434 downregulated, and 7.4% of differentially expressed
genes coded for transcription factor proteins. Analysis of
WikiPathways using PathVisio suggested changes in gene
expression in response to maternal folate depletion may have
influenced 13 biological pathways (“Striated Muscle Con-
traction, Adipogenesis genes, Fatty Acid Biosynthesis, Iron
Homeostasis, TGF Beta Signaling Pathway, miR-1 in cardiac
development, One-carbon metabolism and related pathways,
EPO Receptor Signaling, Spinal Cord Injury, Alanine and
aspartate metabolism, Methylation, and Osteoblast”; (McKay
et al., “Organ-specific gene expression changes in the fetal
liver and placenta in response to maternal folate depletion,”
currently under review).
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Figure 2. Chromosome locations of genes with methylation change in response to low maternal folate intake in the fetal liver. Green
arrows represent hypermethyled genes, orange arrows represent hypomethylated genes.
3.2 Influence of maternal folate intake during
pregnancy on DNA methylation in the fetal liver
In response to maternal folate depletion, 333 genes were dif-
ferentially methylated in the fetal liver of which 247 were hy-
permethylated and 86 were hypomethylated (see Supporting
Information Table 1 for full gene lists). Methylation changes
were distributed across the genome rather than being local-
ized to specific chromosomal regions (Fig. 2).
Pathway analysis using PathVisio found 12WikiPathways
in which a significant number of genes had altered methyla-
tion in the fetal liver in response to low maternal folate in-
take (Table 1). Additionally, KEGG pathway analysis revealed
that inadequate maternal folate intake resulted in a signifi-
cant number of genes in the “steroid hormone biosynthesis”
pathway with altered methylation in the fetal liver (Table 2).
However, Gene Ontology analysis found no statistically sig-
nificant influence of the reported gene expression changes
on biological processes.
3.3 Integration of gene expression and DNA
methylation changes in response to low
maternal folate intake in the fetal liver
In the fetal liver, 989 genes showed altered expression and
333 had altered methylation in response to maternal folate
depletion but, of these, only 16 genes had both expression
and methylation changes (Table 3 and Fig. 3). Furthermore,
only seven of these genes displayed the expected inverse
relationship between change in gene expression and change
in promoter methylation (Table 3 and Fig. 3).
PGE analysis was carried out to search for regions where
the genome was overrepresented as a result of the mater-
nal folate intervention. In response to low maternal folate
intake, 124, 105, 50, and 18 genomic regions were found to
be overrepresented as a result of upregulation, downregu-
lation, hypermethylation, and hypomethylation, respectively,
in the fetal liver (Supporting Information Tables 2–5). Map-
ping of these regions to chromosomal locations suggests that,
while there were regions of the genome in which expression
changes were not associated withmethylation changes, in the
majority of cases, gene expression and methylation changes
occurred in neighboring regions (Fig. 4).
No common GO processes or KEGG pathways were
identified that showed differential gene expression and dif-
ferential gene methylation in the fetal liver response to
maternal folate depletion. However, the Wikipathways one-
carbon metabolism and related pathways, methylation, and
osteoblast showed both expression and methylation changes
in the fetal liver from folate-depleted mothers (Supporting
Information Figs. 1–3).
4 Discussion
We hypothesized that DNAmethylationmay be an important
mechanism involved in transcriptional changes in the fetal
liver in response to low maternal folate intake during preg-
nancy, and therefore that gene expression changes would be
concomitant with gene promotermethylation changes.While
other regulatory mechanisms could contribute to the alter-
ations in gene expression that we have observed (McKay et al.,
“Organ-specific gene expression changes in the fetal liver and
placenta in response to maternal folate depletion,” currently
under review), we specifically hypothesized that DNAmethy-
lation changes may be an important mechanism through
which folate intake influences transcriptional regulation be-
cause of the key role of folate as amethyl donor in one-carbon
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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metabolism and subsequent effect on the availability of SAM
for the methylation of DNA [21,41].
Using a genome-wide array based approach, we identified
333 genes for which promoter methylation was altered in re-
sponse to low maternal folate intake. We observed that the
majority of the promoter regions that we interrogated appear
to be protected from such epigenetic change. Since folate is
a key input driving the one-carbon cycle, we might have an-
ticipated a bigger response in DNA methylation to maternal
folate depletion. Indeed, Chen et al. reported altered methy-
lation of 1034 genes in the liver of 21-day-old rat offspring
in response to feeding a methyl donor deficient diet to their
dams during pregnancy and lactation [42]. However, only
ten genes (ABCA1, ANK3, BRWD1, CHRNB3, DCTN3, JAK-
MIP1, NCF1, PCDHB6, SLC36A3, TMEM188) were found to
have altered methylation in both Chen et al.’s study and the
study described here. The observed difference in methylation
response and very limited overlap in differentially methylated
genes observed between the two studiesmay be due to impor-
tant differences in dietary strategy. Chen et al. used a diet defi-
cient in both folate and vitamin B12, while in our study dietary
vitamin B12 was not altered and folate content was depleted,
not deficient. In addition, the time point and animal mod-
els used may have influenced outcome measures, that is, we
investigated methylation during murine fetal development,
whereas Chen et al. analyzed livers of 21-day-old rat offspring.
Our findings suggest that, when SAM availability is compro-
mised through folate depletion, DNAmethylation is relatively
protected and that other methylation processes, for example,
methylation of proteins and lipids,may be affected to a greater
extent. This hypothesis is in accord with earlier mathematical
modeling studies of folate-mediated one-carbon metabolism
that found that DNA methylation reaction rate was rela-
tively insensitive to changes in folate pool size [43]. Here,
we report changes in promoter methylation and in gene ex-
pression in pathways relating to one-carbon metabolism and
methylation in response to folate depletion, which may sug-
gest that changes in these pathways could be direct feed-
back mechanisms that may protect against more widespread
changes in DNA methylation patterns in response to folate
depletion.
As lowered folate supply leads to reduced SAM availabil-
ity, we expected to see more genes that were hypomethylated
than hypermethyled in the fetal livers from folate-depleted
dams. However, we observed that nearly three times more
gene promoters were hypermethylated as were hypomethy-
lated in response to lowmaternal folate intake. This paradoxi-
cal finding is in accordance with other studies in rodents that
reported that the intake of folate and/or other methyl donors
was inversely associated with DNA methylation [44, 45]. As
the metabolic pathways of folate, choline, methionine, and
vitamins B6 and B12 are closely interconnected [46], it is pos-
sible that the perturbation of one of these pathways may lead
to compensatory changes in others. Indeed in support of this
hypothesis, we observe that folate-induced changes inmethy-
lation and gene expression were likely to have influenced
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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Table 2. KEGG pathways in which genemethylation was altered in the fetal liver in response to lowmaternal folate intake during pregnancy
KEGG pathway term Pathway name Total genes
on pathway
Number of
altered genes
Hypermethylated
genes
Hypomethylated
genes
p-Value
mmu00140 Steroid hormone
biosynthesis
45 4 Ugt1a7c Srd5a2, Sult1e1,
Cyp3a13
0.049
one-carbon metabolism and methylation pathways. Alterna-
tively, the overall pattern of hypermethylation observed here
may be a tissue specific response. Chung et al. reported tissue-
specific methylation patterns that differed between NTD-
affected and control fetuses; 5-methylcytosine (5mC) content
increased in kidney, but decreased in liver from wk 18 to 28
of fetal development in control but not NTD-affected fetuses
[47]. Since lowmaternal serum folate concentrations were ob-
served in NTD mothers, altered tissue-specific methylation
patterns may be associated with low folate status in NTD-
affected pregnancies [47]. However, tissue-specific methy-
lation and maternal serum folate concentration were cor-
related in brain tissue only [47]. It is plausible that other
mechanisms, including disease-related pathology, may be
Table 3. Genes with changes in both gene expression and DNA methylation in the fetal liver in response to low maternal folate intake
during pregnancy
Gene symbol Gene name Ensemble ID Fold change in
gene expression
Fold change in
DNA methylation
9330151L19RIK NA NA –1.28 1.46
CCL11 Chemokine (C–C motif) ligand 11 ENSMUSG00000020676 –1.40 1.42
CYP3A13 Cytochrome P450, family 3, subfamily a,
polypeptide 13
ENSMUSG00000029727 1.59 –1.33
DCBLD2 Discoidin, CUB, and LCCL domain 2 ENSMUSG00000035107 –1.39 –1.21
EBP Emopamil-binding protein ENSMUSG00000031168 1.28 1.70
GLA Galactosidase alpha ENSMUSG00000031266 1.23 1.33
MAT1A Methionine adenosyltransferase I, alpha ENSMUSG00000037798 1.27 1.33
OXCT1 Succinyl-CoA:3-oxoacid-CoA transferase ENSMUSG00000022186 –1.31 1.42
PGM3 Phosphoglucomutase 3, ENSMUSG00000056131 1.24 1.29
PHF14 PHD finger protein 14 ENSMUSG00000029629 –1.32 –1.29
PPP2R1A Protein phosphatase 2, regulatory
subunit a, alpha
ENSMUSG00000007564 1.21 –1.21
RECK Reversion-inducing-cysteine–rich protein
with kazal motifs
ENSMUSG00000028476 –1.33 1.43
SMPX Small-muscle protein, X–Linked ENSMUSG00000041476 –13.40 1.43
SOX30 SRY (sex-determining region Y)–Box 30 ENSMUSG00000040489 –1.26 –1.27
SRD5A2 Steroid-5-alpha-reductase ENSMUSG00000038541 –1.46 –1.21
TRAK1 Trafficking protein, kinesin binding 1 ENSMUSG00000032536 –1.24 1.31
Figure 3. Scatterplot summarizing the di-
rection and level of fold change in expres-
sion and in DNAmethylation of genes with
alterations in both parameters in fetal liver
in response to maternal folate depletion.
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Figure 4. Chromosome locations for overrepresented regions of gene expression and DNAmethylation changes in response to low mater-
nal folate intake in the fetal liver. (A) Overrepresented regions of upregulated (red arrows), downregulated (blue arrows), hypermethylated
(purple arrows), and hypomethylated (green arrows) genes. (B) Overrepresented regions of upregulated (red arrows) and hypomethylated
(blue arrows) genes. (C) Overrepresented regions of downregulated (red arrows) and hypermethylated (blue arrows) genes.
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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responsible for the observed tissue-specific methylation pat-
terns in NTD-affected pregnancies.
When transcriptomic and methylomic datasets were in-
tegrated, we found just 16 genes that showed changes in
both expression and promoter methylation. Moreover, only
seven of these genes displayed the expected inverse associa-
tion between change in expression and change in methyla-
tion. While nonsynonymous changes in gene expression and
methylation have been reported in a number of integrated
transcriptomic and methylomic studies [42, 48–50], we had
anticipated a stronger correlation between promoter methy-
lation and gene expression in the present study because of
the direct influence of folate supply on the amount of SAM
available for DNA methylation. Chen et al. observed simulta-
neous changes in expression and promoter methylation for
266 genes in the livers of 21-day-old rat offspring born to
mothers fed a methyl donor deficient diet during pregnancy
and lactation, but did not report the direction of methyla-
tion change [42]. There was no overlap between genes with
concomitant expression and methylation changes reported
in Chen et al.’s study and the 16 concomitant genes reported
here, which may be due to differences in study design dis-
cussed above.
It is plausible that the methylation status of a gene pro-
moter may not influence the expression of that specific gene
but could influence expression of a neighboring gene(s). For
example, methylation changes within a cis-acting enhancer
[51] could influence the expression of a neighboring gene
or multiple genes without affecting the gene nearest to the
enhancer’s location. To test this hypothesis we used PGE
analysis to find regions of the genome enriched for changes
in gene expression and methylation in response to maternal
low folate intake. Formost regions ofmethylation change, we
identified gene expression changes in neighboring genomic
regions. This suggests that regional methylation changes,
rather than the more simplistic model of promoter methyla-
tion change, may regulate gene regulation, perhaps through
cis-acting enhancer mechanisms.
In this study, we used the Nimblegen MM8_RefSeq_
promoter methylation array platform to measure genome-
wide methylation in fetal livers in response to maternal fo-
late depletion during pregnancy. A strength of using this
array-based approach is that it enabled us to interrogate the
methylation status of all known promoter regions across the
genome. Given the importance of promoter regions in tran-
scriptional regulation, and the evidence that promotermethy-
lation is associatedwith gene silencing [52], we selected arrays
that allowed quantification of methylation status of promoter
regions (up to 2.6-kb regions) of all well-characterized mouse
genes. However, a limitation of this approach is that we were
unable to capturemethylation changes occurring outside pro-
moter regions that may have been altered in response to fo-
late depletion and that could have caused changes in gene
expression. There is growing evidence that DNAmethylation
at intragenic regions (reviewed in Kulis et al. [53]) and CpG
island shores [54] can influence gene expression patterns.
Moreover, studies of cancer cells show that genes located
in partially methylated domains [55] or long hypomethylated
domains [56, 57] are more likely to be repressed, which adds
further intricacies to the complex relationship between DNA
methylation status and gene expression. Therefore, analysis
of promoter regions only is likely to have restricted capacity to
find synonymous associations between methylation patterns
and gene expression. Finally, although the MeDIP method is
robust in identifying regions of the genome with large-scale
methylation changes, it is less able to discern smaller regions
of methylation changes, which may also be significant in
terms of gene expression. While the integration of genome-
wide and epigenome-wide data that we have undertaken here
can offer insights into the effects of environmental exposures
on gene expression and methylation, due to the limitations
of the methodologies used to measure DNAmethylation, the
full complexity of the relationships betweenDNAmethylation
patterning and gene expression profiles remains to be uncov-
ered. The application of technologies such as next-generation
sequencing to characterize and quantify changes in methyla-
tion may help to elucidate such relationships.
We found limited support for our hypothesis that altered
promoter DNA methylation changes in gene expression in
the fetal liver in response to low maternal folate intake. This
suggests that other transcriptional regulatory mechanisms
are more important in this context. Indeed, it is relevant to
note that, although the presence of DNA methylation within
gene promoters associates well with gene repression, the ab-
sence of DNA methylation in gene promoter regions does
not always correlate with gene expression. For example, only
approximately 50% of genes are expressed in particular cell
types during early embryonic development when most of the
genome is unmethylated [58], highlighting the importance
of other regulatory mechanisms in determining patterns of
gene expression. While we have not formally investigated
other mechanisms of transcriptional control such as the role
of enhancers, silencers, activators, or other epigenetic mech-
anisms, our reported transcriptomic data show that 7% of the
genes that were differentially expressed in response to ma-
ternal folate depletion encoded transcription factors. These
changes in transcription factors are likely to have been respon-
sible for the altered expression of other multiple genes and,
therefore, could explain some of the discordance observed
between gene expression and DNA methylation observed in
this study.
In summary, we observed that low maternal folate supply
before mating and during pregnancy influences both expres-
sion and DNA methylation of multiple genes in the fetal
liver. However, at an individual gene level, there was little
overlap between genes showing altered expression and those
showing altered promoter methylation. While the relation-
ship between DNAmethylation and gene expression changes
in this model remains unclear, both are likely to be involved
in modulating programming of the offspring in response to
early-life folate depletion and is revealed as adverse effects
on offspring health in later life [59]. Since epidemiological
C© 2016 The Authors. Molecular Nutrition & Food Research Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.mnf-journal.com
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evidence links inadequate folate intake during pregnancy
with increased risk of a range of adverse pregnancy and
childhood health-related outcomes in humans [4–16], find-
ings from this animal model suggest that DNA methylation
may be a mediating mechanism linking folate status and
such outcomes. Folate inadequacy is common in women of
child-bearing age and has multiple public health implica-
tions, perhaps especially in those who are also obese [60].
Further knowledge of the underlying molecular changes as-
sociated with inadequate folate intake during pregnancy may
illuminate the causal pathways to disease and lead to potential
biomarkers for disease screening programs.
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